Quality-of-Life Utility Values for Erectile Function and Sildenafil Treatment

Author： Kenneth J. Smith   Mark S. Roberts  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.2, 2005-01, pp. : 99-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction

By Vitezic D.  

Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. : 255-265

Adis International

Access to resources Recommend Favorite

Intermittent Claudication: Pharmacoeconomic and Quality-of-Life Aspects of Treatment

By Brevetti G.   Annecchini R.   Bucur R.  

PharmacoEconomics, Vol. 20, Iss. 3, 2002-01 ,pp. : 169-181

Adis International

Access to resources Recommend Favorite

Safety of sildenafil in the treatment of erectile dysfunction in patients with obstructive sleep apnoea

By Perimenis Petros   Giannitsas Konstantinos  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations

By Wisløff F.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 329-341

Adis International

Access to resources Recommend Favorite

Drug Treatment of Overactive Bladder: Efficacy, Cost and Quality-of-Life Considerations

By Hashim Hashim   Paul Abrams  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1643-1656

Adis International

Access to resources Recommend Favorite